Effect of disease-modifying therapies on subcortical gray matter atrophy in multiple sclerosis

BACKGROUND: The effects of disease-modifying therapies (DMTs) on region-specific brain atrophy in multiple sclerosis (MS) are unclear. OBJECTIVE: To determine the effects of higher versus lower efficacy DMTs on rates of brain substructure atrophy in MS. METHODS: A non-randomized, observational cohor...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Mult Scler
Main Authors: Sotirchos, Elias S., Gonzalez-Caldito, Natalia, Dewey, Blake E., Fitzgerald, Kathryn C., Glaister, Jeffrey, Filippatou, Angeliki, Ogbuokiri, Esther, Feldman, Sydney, Kwakyi, Ohemaa, Risher, Hunter, Crainiceanu, Ciprian, Pham, Dzung L., Van Zijl, Peter C., Mowry, Ellen M., Reich, Daniel S., Prince, Jerry L., Calabresi, Peter A., Saidha, Shiv
Format: Artigo
Jezik:Inglês
Izdano: 2019
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6689465/
https://ncbi.nlm.nih.gov/pubmed/30741108
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458519826364
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki